ACTRN12620000864921尚未招募未知
A combined data gathering and diagnostic test accuracy study to test the feasibility of using an acoustic belt for differential diagnosis of gastrointestinal diseases and disorders.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 365
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years(—)
- 性别
- All
入选标准
- •Data gathering stage
- •Patients presenting for first investigation of lower gastrointestinal symptoms with a gastroenterologist, who receive a diagnosis of coeliac disease (confirmed via distal duodenal biopsy after positive serology), Crohn’s disease or ulcerative colitis (confirmed via Upper GI endoscopy, or colonoscopy or sigmoidoscopy and biopsy).
- •Diagnostic Test Accuracy study
- •Additional inclusion criteria for the DTA study: Patients presenting for first investigation of lower gastrointestinal symptoms with a gastroenterologist, who receive a diagnosis of IBS (confirmed through colonoscopy negative for organic disease), Crohn’s disease, colitis or coeliac disease (confirmed as above).
排除标准
- •We will exclude participants with a learning disability of poor understanding of English, which means they are unable to provide informed consent or understand the Rome IV symptom criteria questions.
- •We will exclude individuals with a severe allergy to milk proteins (not lactose) or soy.
- •We will also exclude individuals who have been diagnosed with the following conditions: cancer anywhere in the GI tract, current infection of the GI tract, HIV infection, diabetes or an eating disorder. We will also exclude those with neurological disease or damage that may impair gastrointestinal motility. We will exclude individuals who are pregnant, who have undergone bariatric surgery or resection of any part of their bowels and those regularly taking high doses of NSAIDs or opiates. These factors all affect sounds from the abdomen.
- •Participants who cannot undertake the recording visit within 3 weeks from the gastroenterologist’s preliminary diagnosis or who fail to fast or complete recordings, e.g., due to displaying respiratory symptoms, will also be excluded.
- •In most cases the preliminary diagnosis will match the final diagnosis provided by the gastroenterologist. In rare cases the histology results may lead to a participant moving between gastrointestinal conditions or being excluded.
研究者
相似试验
招募中
不适用
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).Acute Coronary SyndromeACTRN12609000057280Health Research Council of New Zealand2,000
尚未招募
Unknown
Data acquisition and accuracy confirmation test for device measurements, fingertip blood glucose levels, and venous blood glucose levelsot applicableJPRN-UMIN000049107Suntory Global Innovation Center Ltd.112
招募中
不适用
Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skiL10.0L12.0Pemphigus vulgarisBullous pemphigoidDRKS00027499niversitätsklinikum der RWTH Aachen40
尚未招募
不适用
Field testing the CLEFT-QQuality of LifePatient Reported Outcome MeasureCleft patientsNL-OMON24585niversity Medical Centre Groningen200
已完成
不适用
Field testing of a Patient-Reported Outcome Measure for Cleft Lip and Palate: The CLEFT-Qcleft lip and palate10040789NL-OMON42276niversitair Medisch Centrum Groningen200
